Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chika Sakai

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|November 2, 2020
[Pharmacological properties and clinical effects of the ADHD drug, Lisdexamfetamine (Vyvanse<sup>®</sup> capsules 20 mg and 30 mg)]Chika Sakai
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 28, 2018
[Immunosuppressive Environment in Tumors]Chika Sakai, Hiroyoshi Nishikawa
Biochimica Et Biophysica Acta|January 10, 2012
Mitochondrial fumarate reductase as a target of chemotherapy: from parasites to cancer cellsChika Sakai, Eriko Tomitsuka, Hiroyasu Esumi, et al.
Biological & Pharmaceutical Bulletin|April 4, 2014
Inhibition of cancer cell growth by GRP78 siRNA lipoplex via activation of unfolded protein responseKazushi Matsumura, Chika Sakai, Shigeru Kawakami, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 11, 2022
An exploratory study of factors associated with long-term, high-dose opioid prescription in cancer patients in Japan based on a medical claims databaseTatsuya Hashimoto, Hirokazu Mishima, Chika Sakai, et al.
Mitochondrion|September 7, 2013
Type II Fp of human mitochondrial respiratory complex II and its role in adaptation to hypoxia and nutrition-deprived conditionsChika Sakai, Eriko Tomitsuka, Makoto Miyagishi, et al.
Cancers|May 14, 2025
Real-World Treatment Outcomes of Different Sequencing Options with Daratumumab, Lenalidomide, and Dexamethasone in Patients with Transplant-Ineligible Multiple Myeloma in JapanKazuhito Suzuki, Yuma Fujimori, Chika Sakai, et al.
Human Mutation|November 14, 2014
ECHS1 mutations cause combined respiratory chain deficiency resulting in Leigh syndromeChika Sakai, Seiji Yamaguchi, Masayuki Sasaki, et al.
Neuropsychopharmacology Reports|December 11, 2020
Efficacy and safety of guanfacine extended-release in Japanese adults with attention-deficit/hyperactivity disorder: Exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled studyNoriyuki Naya, Chika Sakai, Daiki Okutsu, et al.
Cureus|December 27, 2021
The Burden of Undiagnosed Adults With Attention-Deficit/Hyperactivity Disorder Symptoms in Japan: A Cross-Sectional StudyNoriyuki Naya, Toshinaga Tsuji, Nobuhiro Nishigaki, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|November 2, 2020
[Pharmacological properties and clinical effects of the ADHD drug, Lisdexamfetamine (Vyvanse<sup>®</sup> capsules 20 mg and 30 mg)]Chika Sakai
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 28, 2018
[Immunosuppressive Environment in Tumors]Chika Sakai, Hiroyoshi Nishikawa
Biochimica Et Biophysica Acta|January 10, 2012
Mitochondrial fumarate reductase as a target of chemotherapy: from parasites to cancer cellsChika Sakai, Eriko Tomitsuka, Hiroyasu Esumi, et al.
Biological & Pharmaceutical Bulletin|April 4, 2014
Inhibition of cancer cell growth by GRP78 siRNA lipoplex via activation of unfolded protein responseKazushi Matsumura, Chika Sakai, Shigeru Kawakami, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 11, 2022
An exploratory study of factors associated with long-term, high-dose opioid prescription in cancer patients in Japan based on a medical claims databaseTatsuya Hashimoto, Hirokazu Mishima, Chika Sakai, et al.
Mitochondrion|September 7, 2013
Type II Fp of human mitochondrial respiratory complex II and its role in adaptation to hypoxia and nutrition-deprived conditionsChika Sakai, Eriko Tomitsuka, Makoto Miyagishi, et al.
Cancers|May 14, 2025
Real-World Treatment Outcomes of Different Sequencing Options with Daratumumab, Lenalidomide, and Dexamethasone in Patients with Transplant-Ineligible Multiple Myeloma in JapanKazuhito Suzuki, Yuma Fujimori, Chika Sakai, et al.
Human Mutation|November 14, 2014
ECHS1 mutations cause combined respiratory chain deficiency resulting in Leigh syndromeChika Sakai, Seiji Yamaguchi, Masayuki Sasaki, et al.
Neuropsychopharmacology Reports|December 11, 2020
Efficacy and safety of guanfacine extended-release in Japanese adults with attention-deficit/hyperactivity disorder: Exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled studyNoriyuki Naya, Chika Sakai, Daiki Okutsu, et al.
Cureus|December 27, 2021
The Burden of Undiagnosed Adults With Attention-Deficit/Hyperactivity Disorder Symptoms in Japan: A Cross-Sectional StudyNoriyuki Naya, Toshinaga Tsuji, Nobuhiro Nishigaki, et al.
Pageof 3